In addition, from our global proteomics analyses, we identified ATXN2 as a “top hit”; apart from one report regarding ATXN2 as a novel locus in chronic kidney disease (71), no other findings have been thus far reported with respect to kidney cancer. The gene discussed is ATXN2; the disease is chronic kidney disease.